Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (91-100 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
British Journal of Haematology|July 26, 2018
A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosisCamille Bigenwald, Laurence Fardet, Paul Coppo, et al.
European Journal of Haematology|November 27, 2015
Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceMyriam Soucemarianadin, Ygal Benhamou, Yahsou Delmas, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell diseaseJulien Demagny, Aurélie Driss, Alain Stepanian, et al.
Journal of Clinical Medicine|February 15, 2022
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome DiagnosisLaure Burguet, Benjamin Taton, Mathilde Prezelin-Reydit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2022
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and HaemostasisKathrin Eller, Paul Knoebl, Sevcan A Bakkaloglu, et al.
Critical Care (London, England)|March 22, 2023
Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpuraJérémie Joffre, Lisa Raia, Tomas Urbina, et al.
Thrombosis and Haemostasis|October 13, 2018
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman SyndromeBérangère S Joly, Pierre Boisseau, Elien Roose, et al.
Blood|May 2, 2012
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpuraMarie Moatti-Cohen, Céline Garrec, Martine Wolf, et al.
Thrombosis and Haemostasis|July 15, 2026
Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic PurpuraPaul Coppo, Marie Ann Scully, Javier de la Rubia, et al.
Pageof 20

Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
British Journal of Haematology|July 26, 2018
A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosisCamille Bigenwald, Laurence Fardet, Paul Coppo, et al.
European Journal of Haematology|November 27, 2015
Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceMyriam Soucemarianadin, Ygal Benhamou, Yahsou Delmas, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell diseaseJulien Demagny, Aurélie Driss, Alain Stepanian, et al.
Journal of Clinical Medicine|February 15, 2022
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome DiagnosisLaure Burguet, Benjamin Taton, Mathilde Prezelin-Reydit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2022
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and HaemostasisKathrin Eller, Paul Knoebl, Sevcan A Bakkaloglu, et al.
Critical Care (London, England)|March 22, 2023
Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpuraJérémie Joffre, Lisa Raia, Tomas Urbina, et al.
Thrombosis and Haemostasis|October 13, 2018
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman SyndromeBérangère S Joly, Pierre Boisseau, Elien Roose, et al.
Blood|May 2, 2012
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpuraMarie Moatti-Cohen, Céline Garrec, Martine Wolf, et al.
Thrombosis and Haemostasis|July 15, 2026
Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic PurpuraPaul Coppo, Marie Ann Scully, Javier de la Rubia, et al.
Pageof 20